Splicing-factor alterations in cancers
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory elements or changes in components of the splicing machinery. This review summarizes our current understanding of the role of splicing-factor alterations in human cancers. We describe splicing-factor alterations detected in human tumors and the resulting changes in splicing, highlighting cell-type-specific similarities and differences. We review the mechanisms of splicing-factor regulation in normal and cancer cells. Finally, we summarize recent efforts to develop novel cancer therapies, based on targeting either the oncogenic splicing events or their upstream splicing regulators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · cited 2×
“…breast tumors and 4% of luminal breast tumors (Ellis et al. 2012; Maguire et al. 2015), as well as in 3% of pancreatic ductal adenocarcinomas (Biankin et al. 2012), whereas mutations of residues R625 and K666 are found in 15%–29% of recruiting U2AF to the upstream 3′SS and U1 snRNP to the…”
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029 · cited 8×
“SF3B1mutations are found in a variety of myeloid malignancies, with extremely high recurrence (48%–57%) in MDS subtypes that show increased ring sideroblasts (RARS/ RCMD-RS) (Malcovati et al. 2011; Yoshida et al. 2011; Damm et al. 2012; Patnaik et al. 2012; Visconte et al. 2012), as well in 6%–26% of CLLs (Table 1).”
InfluentialClinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · cited 9×
“Wild-type SRSF2 recognizes the consensus binding motifs CCNG and GGNG with similar affinity, whereas SRSF2P95H preferentially binds T N T N Differential splicing patterns in tumors (T) vs normal (N) exon 1 exon 2 exon 3 T N T N Signaling pathways Transcriptional upregulation (e.g., by MYC) TF Somatic mutations (e.g.,…”
InfluentialSomatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222 · cited 1×
“…splicing factor 2), U2AF1 (U2 small nuclear RNA auxiliary factor 1), and ZRSR2 (zinc finger RNA binding motif and serine/arginine rich 2), and almost always as somatic heterozygous missense mutations that are mutually exclusive (Papaemmanuil et al. 2011; Wang et al. 2011; Yoshida et al. 2011).”
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Self-citationThe SR protein family of splicing factors: master regulators of gene expression
Long, J. C., & Caceres, J. F. (2009) · Biochemical Journal · doi:10.1042/bj20081501 · Cited by 1,137
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Whole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Self-citationBueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements
Lareau, L. F., Inada, M., Green, R. E., Wengrod, J. C., & Brenner, S. E. (2007) · Nature · doi:10.1038/nature05676 · Cited by 681
Colwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J. L., Bell, J. C., & Duncan, P. I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00357.x · Cited by 580
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 580
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.025 · Cited by 579
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Kim, E., Ilagan, J. O., Liang, Y., Daubner, G. M., Lee, S. C.-W., Ramakrishnan, A., Li, Y., Chung, Y. R., Micol, J.-B., Murphy, M. E., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.006 · Cited by 575
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
A serine kinase regulates intracellular localization of splicing factors in the cell cycle
Gui, J.-F., Lane, W. S., & Fu, X.-D. (1994) · Nature · doi:10.1038/369678a0 · Cited by 542
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., et al. (2014) · Science · doi:10.1126/science.1250127 · Cited by 524 · cited 1×
“For example, several groups identified compounds that enhance SMN2 exon 7 splicing to promote the production of a full-length SMN protein (Hastings et al. 2009; Naryshkin et al. 2014; Palacino et al. 2015), an approach with therapeutic potential for spinal muscular atrophy.”
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
Harbour, J. W., Roberson, E. D. O., Anbunathan, H., Onken, M. D., Worley, L. A., & Bowcock, A. M. (2013) · Nature Genetics · doi:10.1038/ng.2523 · Cited by 516
Malcovati, L., Papaemmanuil, E., Bowen, D. T., Boultwood, J., Della Porta, M. G., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 498
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Hsu, T. Y.-T., Simon, L. M., Neill, N. J., Marcotte, R., Sayad, A., Bland, C. S., Echeverria, G. V., Sun, T., Kurley, S. J., Tyagi, S., et al. (2015) · Nature · doi:10.1038/nature14985 · Cited by 492
Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., & Gertler, F. B. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002218 · Cited by 461
Darman, R. B., Seiler, M., Agrawal, A. A., Lim, K. H., Peng, S., Aird, D., Bailey, S. L., Bhavsar, E. B., Chan, B., Colla, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.053 · Cited by 453
Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447
Self-citationBejar, R., Stevenson, K. E., Caughey, B. A., Abdel-Wahab, O., Steensma, D. P., Galili, N., Raza, A., Kantarjian, H., Levine, R. L., Neuberg, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7379 · Cited by 441
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jädersten, M., Jansson, M., Elena, C., Gallì, A., Walldin, G., Della Porta, M. G., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633537 · Cited by 434
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Furney, S. J., Pedersen, M., Gentien, D., Dumont, A. G., Rapinat, A., Desjardins, L., Turajlic, S., Piperno-Neumann, S., de la Grange, P., Roman-Roman, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0330 · Cited by 434
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1837 · Cited by 432
Clower, C. V., Chatterjee, D., Wang, Z., Cantley, L. C., Vander Heiden, M. G., & Krainer, A. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914845107 · Cited by 424 · cited 7×
“Wild-type SRSF2 recognizes the consensus binding motifs CCNG and GGNG with similar affinity, whereas SRSF2P95H preferentially binds T N T N Differential splicing patterns in tumors (T) vs normal (N) exon 1 exon 2 exon 3 T N T N Signaling pathways Transcriptional upregulation (e.g., by MYC) TF Somatic mutations (e.g.,…”
InfluentialSelf-citationThol, F., Kade, S., Schlarmann, C., Löffeld, P., Morgan, M., Krauter, J., Wlodarski, M. W., Kölking, B., Wichmann, M., Görlich, K., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399337 · Cited by 419
Dynamic Protein-Protein Interaction Wiring of the Human Spliceosome
Hegele, A., Kamburov, A., Grossmann, A., Sourlis, C., Wowro, S., Weimann, M., Will, C. L., Pena, V., Lührmann, R., & Stelzl, U. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.034 · Cited by 414
The spliceosome as a target of novel antitumour drugs
Bonnal, S., Vigevani, L., & Valcárcel, J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3823 · Cited by 405
Xiao, S. H., & Manley, J. L. (1997) · Genes & Development · doi:10.1101/gad.11.3.334 · Cited by 395
Xu, X., Yang, D., Ding, J.-H., Wang, W., Chu, P.-H., Dalton, N. D., Wang, H.-Y., Bermingham, J. R., Ye, Z., Liu, F., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.036 · Cited by 394
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E., Tirode, F., Constantinou, A., Piperno-Neumann, S., Roman-Roman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10615 · Cited by 386
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
Yae, T., Tsuchihashi, K., Ishimoto, T., Motohara, T., Yoshikawa, M., Yoshida, G. J., Wada, T., Masuko, T., Mogushi, K., Tanaka, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms1892 · Cited by 383
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Koh, C. M., Bezzi, M., Low, D. H. P., Ang, W. X., Teo, S. X., Gay, F. P. H., Al-Haddawi, M., Tan, S. Y., Osato, M., Sabò, A., et al. (2015) · Nature · doi:10.1038/nature14351 · Cited by 380
Bechara, E. G., Sebestyén, E., Bernardis, I., Eyras, E., & Valcárcel, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.010 · Cited by 372
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Makishima, H., Visconte, V., Sakaguchi, H., Jankowska, A. M., Abu Kar, S., Jerez, A., Przychodzen, B., Bupathi, M., Guinta, K., Afable, M. G., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399774 · Cited by 370
SRSF1-Regulated Alternative Splicing in Breast Cancer
Anczuków, O., Akerman, M., Cléry, A., Wu, J., Shen, C., Shirole, N. H., Raimer, A., Sun, S., Jensen, M. A., Hua, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.005 · Cited by 367
Self-citationThe significant other: splicing by the minor spliceosome
Turunen, J. J., Niemelä, E. H., Verma, B., & Frilander, M. J. (2013) · WIREs RNA · doi:10.1002/wrna.1141 · Cited by 349
Lee, S. C.-W., Dvinge, H., Kim, E., Cho, H., Micol, J.-B., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4097 · Cited by 347
Cancer-associated regulation of alternative splicing
Venables, J. P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1608 · Cited by 342
Weyn-Vanhentenryck, S. M., Mele, A., Yan, Q., Sun, S., Farny, N., Zhang, Z., Xue, C., Herre, M., Silver, P. A., Zhang, M. Q., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.005 · Cited by 333 · cited 1×
“Mutations or deletions in RBFOX1 and RBFOX3 are found in epilepsy patients (Bhalla et al. 2004; Lal et al. 2013a,b), whereas copy-number variations in RBFOX1 are associated with autism spectrum disorders and spinocerebellar ataxias (Bill et al. 2013; Weyn-Vanhentenryck et al. 2014).”
Self-citationThe splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain
Gehman, L. T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Ares, M., Mody, I., & Black, D. L. (2011) · Nature Genetics · doi:10.1038/ng.841 · Cited by 331 · cited 1×
“Mouse models with Rbfox KO or KD show extensive defects in neuronal and muscle physiology, suggesting that these proteins play key roles in normal development (Gehman et al. 2011, 2012).”
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I
Rossi, F., Labourier, E., Forné, T., Divita, G., Derancourt, J., Riou, J. F., Antoine, E., Cathala, G., Brunel, C., & Tazi, J. (1996) · Nature · doi:10.1038/381080a0 · Cited by 326
Wang, H.-Y., Lin, W., Dyck, J. A., Yeakley, J. M., Songyang, Z., Cantley, L. C., & Fu, X.-D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.737 · Cited by 324
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Moore, M. J., Wang, Q., Kennedy, C. J., & Silver, P. A. (2010) · Cell · doi:10.1016/j.cell.2010.07.019 · Cited by 316
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs
Sureau, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1785 · Cited by 310
The genomic landscape of juvenile myelomonocytic leukemia
Stieglitz, E., Taylor-Weiner, A. N., Chang, T. Y., Gelston, L. C., Wang, Y.-D., Mazor, T., Esquivel, E., Yu, A., Seepo, S., Olsen, S. R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3400 · Cited by 301
Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
Das, S., & Krainer, A. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0131 · Cited by 298
Self-citationChaudhury, A., Chander, P., & Howe, P. H. (2010) · RNA · doi:10.1261/rna.2254110 · Cited by 292
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Shirai, C. L., Ley, J. N., White, B. S., Kim, S., Tibbitts, J., Shao, J., Ndonwi, M., Wadugu, B., Duncavage, E. J., Okeyo-Owuor, T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.008 · Cited by 287 · cited 1×
“The MDS mutations in U2AF1 alter RNA splicing and promote mis-splicing of genes in ways that presumably contribute to abnormal hematopoiesis (Graubert et al. 2012; Quesada et al. 2012; Przychodzen et al. 2013; Brooks et al. 2014; Ilagan et al. 2015; Okeyo-Owuor et al. 2015; Shirai et al. 2015).”
U2AF1 mutations alter splice site recognition in hematological malignancies
Ilagan, J. O., Ramakrishnan, A., Hayes, B., Murphy, M. E., Zebari, A. S., Bradley, P., & Bradley, R. K. (2015) · Genome Research · doi:10.1101/gr.181016.114 · Cited by 287
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284 · cited 1×
“This mutation pat- malignancies, such as de novo AML, CLL, or MDS, including mutations in PRPF8, SF3A1, LUCL7L2, SF1, U2AF2, HNRNPK, SRSF6, SRSF1, SRSF7, TRA2β, SRRM2, DDX1, DDX23, CELF4 (Makishima et al. 2012; Quesada et al. 2012; The Cancer Genome Atlas Research Network 2013; Walter et al. 2013).”
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
Bandopadhayay, P., Ramkissoon, L. A., Jain, P., Bergthold, G., Wala, J., Zeid, R., Schumacher, S. E., Urbanski, L., O'Rourke, R., Gibson, W. J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3500 · Cited by 277
Zhou, Z., Qiu, J., Liu, W., Zhou, Y., Plocinik, R. M., Li, H., Hu, Q., Ghosh, G., Adams, J. A., Rosenfeld, M. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.014 · Cited by 273
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
Krönke, J., Bullinger, L., Teleanu, V., Tschürtz, F., Gaidzik, V. I., Kühn, M. W. M., Rücker, F. G., Holzmann, K., Paschka, P., Kapp-Schwörer, S., et al. (2013) · Blood · doi:10.1182/blood-2013-01-479188 · Cited by 273
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah-Zadeh, M., Welsh, G. I., Cheung, M.-K., Ni, L., Kase, S., Rennel, E. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.016 · Cited by 253
The Coupling of Alternative Splicing and Nonsense-Mediated mRNA Decay
Lareau, L. F., Brooks, A. N., Soergel, D. A. W., Meng, Q., & Brenner, S. E. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-77374-2_12 · Cited by 252
A molecular link between SR protein dephosphorylation and mRNA export
Huang, Y., Yario, T. A., & Steitz, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403533101 · Cited by 243
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato-Otsubo, A., Kohlmann, A., Sanada, M., Grossmann, V., Sundaresan, J., Shiraishi, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7042 · Cited by 240
The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
Zong, F.-Y., Fu, X., Wei, W.-J., Luo, Y.-G., Heiner, M., Cao, L.-J., Fang, Z., Fang, R., Lu, D., Ji, H., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004289 · Cited by 235
Golan-Gerstl, R., Cohen, M., Shilo, A., Suh, S.-S., Bakàcs, A., Coppola, L., & Karni, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4410 · Cited by 232
Xu, Y., Gao, X. D., Lee, J.-H., Huang, H., Tan, H., Ahn, J., Reinke, L. M., Peter, M. E., Feng, Y., Gius, D., et al. (2014) · Genes & Development · doi:10.1101/gad.241968.114 · Cited by 225
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
Visconte, V, Makishima, H., Jankowska, A., Szpurka, H., Traina, F., Jerez, A., O'Keefe, C., Rogers, H. J., Sekeres, M. A., Maciejewski, J. P., et al. (2012) · Leukemia · doi:10.1038/leu.2011.232 · Cited by 213
The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function
Gehman, L. T., Meera, P., Stoilov, P., Shiue, L., O'Brien, J. E., Meisler, M. H., Ares, M., Otis, T. S., & Black, D. L. (2012) · Genes & Development · doi:10.1101/gad.182477.111 · Cited by 213
DeBoever, C., Ghia, E. M., Shepard, P. J., Rassenti, L., Barrett, C. L., Jepsen, K., Jamieson, C. H. M., Carson, D., Kipps, T. J., & Frazer, K. A. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004105 · Cited by 211
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi, A., Miyazawa, K., Miyazono, K., et al. (2012) · Oncogene · doi:10.1038/onc.2011.493 · Cited by 209
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Jia, R., Li, C., McCoy, J. P., Deng, C.-X., & Zheng, Z.-M. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.806 · Cited by 206
Warzecha, C. C., Shen, S., Xing, Y., & Carstens, R. P. (2009) · RNA Biology · doi:10.4161/rna.6.5.9606 · Cited by 205
Patnaik, M. M., Lasho, T. L., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Garcia-Manero, G., Steensma, D. P., Pardanani, A., Hanson, C. A., & Tefferi, A. (2012) · Blood · doi:10.1182/blood-2011-09-377994 · Cited by 202
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Das, S., Anczuków, O., Akerman, M., & Krainer, A. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.001 · Cited by 202
Self-citationA MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control
Sun, S., Zhang, Z., Sinha, R., Karni, R., & Krainer, A. R. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1750 · Cited by 201
Self-citationBCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells
Zhou, X., Li, X., Cheng, Y., Wu, W., Xie, Z., Xi, Q., Han, J., Wu, G., Fang, J., & Feng, Y. (2014) · Nature Communications · doi:10.1038/ncomms5581 · Cited by 194
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Wu, H., Sun, S., Tu, K., Gao, Y., Xie, B., Krainer, A. R., & Zhu, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.021 · Cited by 191
Self-citationFox-1 family of RNA-binding proteins
Kuroyanagi, H. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0120-5 · Cited by 187 · cited 2×
“(RBM9), and RBFOX3 (NeuN), which control tissue-specific alternative splicing of exons in brain, muscle, epithelial, and mesenchymal cells, as well as in embryonic stem cells (Kuroyanagi 2009).”
Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao, W., Jamison, S. F., & García-Blanco, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 186
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
Cohen‐Eliav, M., Golan‐Gerstl, R., Siegfried, Z., Andersen, C. L., Thorsen, K., Orntoft, T. F., Mu, D., & Karni, R. (2012) · The Journal of Pathology · doi:10.1002/path.4129 · Cited by 179
Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20
Jumaa, H., Wei, G., & Nielsen, P. J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80394-7 · Cited by 178
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Maguire, S. L., Leonidou, A., Wai, P., Marchiò, C., Ng, C. K., Sapino, A., Salomon, A., Reis‐Filho, J. S., Weigelt, B., & Natrajan, R. C. (2015) · The Journal of Pathology · doi:10.1002/path.4483 · Cited by 175
Venables, J. P., Brosseau, J., Gadéa, G., Klinck, R., Prinos, P., Beaulieu, J., Lapointe, E., Durand, M., Thibault, P., Tremblay, K., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-12 · Cited by 174
Brooks, A. N., Choi, P. S., de Waal, L., Sharifnia, T., Imielinski, M., Saksena, G., Pedamallu, C. S., Sivachenko, A., Rosenberg, M., Chmielecki, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087361 · Cited by 174
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
LeFave, C. V., Squatrito, M., Vorlová, S., Rocco, G., Brennan, C., Holland, E. C., Pan, Y., & Cartegni, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.259 · Cited by 172
Valacca, C., Bonomi, S., Buratti, E., Pedrotti, S., Baralle, F. E., Sette, C., Ghigna, C., & Biamonti, G. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001073 · Cited by 172
Hayes, G. M., Carrigan, P. E., & Miller, L. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2969 · Cited by 171
Carpenter, B., McKay, M., Dundas, S. R., Lawrie, L. C., Telfer, C., & Murray, G. I. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603349 · Cited by 170
Regulated Cellular Partitioning of SR Protein-specific Kinases in Mammalian Cells
Ding, J., Zhong, X.-Y., Hagopian, J. C., Cruz, M. M., Ghosh, G., Feramisco, J. R., Adams, J. A., & Fu, X. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-10-0963 · Cited by 169
Li, X., Wang, J., & Manley, J. L. (2005) · Genes & Development · doi:10.1101/gad.1359305 · Cited by 168
Lareau, L. F., & Brenner, S. E. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv002 · Cited by 166
Identification of recurrent regulated alternative splicing events across human solid tumors
Danan-Gotthold, M., Golan‐Gerstl, R., Eisenberg, E., Meir, K., Karni, R., & Levanon, E. Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv210 · Cited by 164
Bebee, T. W., Park, J. W., Sheridan, K. I., Warzecha, C. C., Cieply, B. W., Rohacek, A. M., Xing, Y., & Carstens, R. P. (2015) · eLife · doi:10.7554/elife.08954 · Cited by 161
Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function
Sen, S., Jumaa, H., & Webster, N. J. G. (2013) · Nature Communications · doi:10.1038/ncomms2342 · Cited by 156
Splicing factor mutations and cancer
Yoshida, K., & Ogawa, S. (2014) · WIREs RNA · doi:10.1002/wrna.1222 · Cited by 155
Ishii, H., Saitoh, M., Sakamoto, K., Kondo, T., Katoh, R., Tanaka, S., Motizuki, M., Masuyama, K., & Miyazawa, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589432 · Cited by 153
Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing
Tazi, J., Kornstädt, U., Rossi, F., Jeanteur, P., Cathala, G., Brunel, C., & Lührmann, R. (1993) · Nature · doi:10.1038/363283a0 · Cited by 149
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Przychodzen, B., Jerez, A., Guinta, K., Sekeres, M. A., Padgett, R., Maciejewski, J. P., & Makishima, H. (2013) · Blood · doi:10.1182/blood-2013-01-480970 · Cited by 149
Bhalla, K., Phillips, H. A., Crawford, J., McKenzie, O. L. D., Mulley, J. C., Eyre, H., Gardner, A. E., Kremmidiotis, G., & Callen, D. F. (2004) · Journal of Human Genetics · doi:10.1007/s10038-004-0145-4 · Cited by 146 · cited 1×
“Mutations or deletions in RBFOX1 and RBFOX3 are found in epilepsy patients (Bhalla et al. 2004; Lal et al. 2013a,b), whereas copy-number variations in RBFOX1 are associated with autism spectrum disorders and spinocerebellar ataxias (Bill et al. 2013; Weyn-Vanhentenryck et al. 2014).”
Gallardo, M., Lee, H. J., Zhang, X., Bueso-Ramos, C., Pageon, L. R., McArthur, M., Multani, A., Nazha, A., Manshouri, T., Parker-Thornburg, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.001 · Cited by 145 · cited 5×
“Hnrnpk KO is embryonic lethal in mice, whereas Hnrnpk haploinsufficiency results in reduced survival, increased tumor formation, genomic instability, and the development of transplantable hematopoietic neoplasms with myeloproliferation (Gallardo et al. 2015).”
InfluentialSplicing factor SRSF6 promotes hyperplasia of sensitized skin
Jensen, M. A., Wilkinson, J. E., & Krainer, A. R. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2756 · Cited by 143
Self-citationDittmar, K. A., Jiang, P., Park, J. W., Amirikian, K., Wan, J., Shen, S., Xing, Y., & Carstens, R. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06536-11 · Cited by 139 · cited 1×
“ESRP splicing targets are enriched in genes involved in cytoskeletal dynamics, cell motility, cell–cell junctions, and pathways involved in EMT, including CD44, ENAH, and FGFR2 isoforms (Warzecha et al. 2009a,b; Shapiro et al. 2011; Dittmar et al. 2012).”
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
Okeyo-Owuor, T., White, B. S., Chatrikhi, R., Mohan, D. R., Kim, S., Griffith, M., Ding, L., Ketkar-Kulkarni, S., Hundal, J., Laird, K. M., et al. (2015) · Leukemia · doi:10.1038/leu.2014.303 · Cited by 137
Splicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.001 · Cited by 130
Self-citationWatermann, D. O., Tang, Y., zur Hausen, A., Jäger, M., Stamm, S., & Stickeler, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3294 · Cited by 128
Sen, S., Langiewicz, M., Jumaa, H., & Webster, N. J. G. (2015) · Hepatology · doi:10.1002/hep.27380 · Cited by 127
He, X., Pool, M. D., Darcy, K. M., Lim, S. B., Auersperg, N., Coon, J. S., & Beck, W. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210307 · Cited by 127
Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons
Wang, Z., Chatterjee, D., Jeon, H. Y., Akerman, M., Vander Heiden, M. G., Cantley, L. C., & Krainer, A. R. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr030 · Cited by 124
Self-citationGrowth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function
Mandal, M., Vadlamudi, R., Nguyen, D., Wang, R.-A., Costa, L., Bagheri-Yarmand, R., Mendelsohn, J., & Kumar, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008514200 · Cited by 123
Tumor suppressor properties of the splicing regulatory factor RBM10
Hernández, J., Bechara, E., Schlesinger, D., Delgado, J., Serrano, L. G., & Valcárcel, J. (2016) · RNA Biology · doi:10.1080/15476286.2016.1144004 · Cited by 122
Dephosphorylation-Dependent Sorting of SR Splicing Factors during mRNP Maturation
Lin, S., Xiao, R., Sun, P., Xu, X., & Fu, X. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.015 · Cited by 121
Targeting the RNA Splicing Machinery as a Novel Treatment Strategy for Pancreatic Carcinoma
Hayes, G. M., Carrigan, P. E., Beck, A. M., & Miller, L. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4065 · Cited by 121
He, X., Ee, P. L. R., Coon, J. S., & Beck, W. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0439 · Cited by 121
Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
Lapuk, A., Marr, H., Jakkula, L., Pedro, H., Bhattacharya, S., Purdom, E., Hu, Z., Simpson, K., Pachter, L., Durinck, S., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0528 · Cited by 116
RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy
Lal, D., Reinthaler, E. M., Altmüller, J., Toliat, M. R., Thiele, H., Nürnberg, P., Lerche, H., Hahn, A., Møller, R. S., Muhle, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073323 · Cited by 113 · cited 1×
“Mutations or deletions in RBFOX1 and RBFOX3 are found in epilepsy patients (Bhalla et al. 2004; Lal et al. 2013a,b), whereas copy-number variations in RBFOX1 are associated with autism spectrum disorders and spinocerebellar ataxias (Bill et al. 2013; Weyn-Vanhentenryck et al. 2014).”
Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia
Yoshida, M., Kataoka, N., Miyauchi, K., Ohe, K., Iida, K., Yoshida, S., Nojima, T., Okuno, Y., Onogi, H., Usui, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415525112 · Cited by 111
The alternative splicing side of cancer
Biamonti, G., Catillo, M., Pignataro, D. S., Montecucco, A., & Ghigna, C. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.016 · Cited by 110
Kurokawa, K., Akaike, Y., Masuda, K., Kuwano, Y., Nishida, K., Yamagishi, N., Kajita, K., Tanahashi, T., & Rokutan, K. (2013) · Oncogene · doi:10.1038/onc.2013.86 · Cited by 110
He, X., Arslan, A. D., Ho, T.-T., Yuan, C., Stampfer, M. R., & Beck, W. T. (2014) · Oncogenesis · doi:10.1038/oncsis.2013.47 · Cited by 109
Zhou, J. M., Allred, D. C., Avis, I. M., Martínez, A., Vos, M. D., Smith, L. M., Treston, A. M., & Mulshine, J. L. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010631915831 · Cited by 107
Meseguer, S., Mudduluru, G., Escamilla, J. M., Allgayer, H., & Barettino, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.167817 · Cited by 107
Expression of splicing factors in human ovarian cancer
Fischer, D., Noack, K., Runnebaum, I. B., Watermann, D. O., Kieback, D., Stamm, S., & Stickeler, E. (2004) · Oncology Reports · doi:10.3892/or.11.5.1085 · Cited by 106
RBM5 as a Putative Tumor Suppressor Gene for Lung Cancer
Sutherland, L. C., Wang, K., & Robinson, A. G. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c6e330 · Cited by 104
Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2
Sun, S., Zhang, Z., Fregoso, O., & Krainer, A. R. (2012) · RNA · doi:10.1261/rna.030486.111 · Cited by 103
Self-citationHe, X., Arslan, A. D., Pool, M. D., Ho, T.-T., Darcy, K. M., Coon, J. S., & Beck, W. T. (2010) · Oncogene · doi:10.1038/onc.2010.426 · Cited by 101
Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
Hastings, M. L., Berniac, J., Liu, Y. H., Abato, P., Jodelka, F. M., Barthel, L., Kumar, S., Dudley, C., Nelson, M. L., Larson, K. C., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000208 · Cited by 97
Self-citationEmerging functions of the Quaking RNA‐binding proteins and link to human diseases
Darbelli, L., & Richard, S. (2016) · WIREs RNA · doi:10.1002/wrna.1344 · Cited by 95
Orchestration of Neurodevelopmental Programs by RBFOX1
Bill, B. R., Lowe, J. K., DyBuncio, C. T., & Fogel, B. L. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00008-3 · Cited by 94 · cited 1×
“Mutations or deletions in RBFOX1 and RBFOX3 are found in epilepsy patients (Bhalla et al. 2004; Lal et al. 2013a,b), whereas copy-number variations in RBFOX1 are associated with autism spectrum disorders and spinocerebellar ataxias (Bill et al. 2013; Weyn-Vanhentenryck et al. 2014).”
Jin, W., McCutcheon, I. E., Fuller, G. N., Huang, E. S., & Cote, G. J. (2000) · PubMed · Cited by 94
Fielding, P., Turnbull, L. S., Prime, W., Walshaw, M. J., & Field, J. K. (1999) · PubMed · Cited by 88
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
Damm, F., Thol, F. R., Kosmider, O., Kade, S., Löffeld, P., Dreyfus, F., Stamatoullas, A., Schmidt, A., Beyne‐Rauzy, O., de Botton, S., et al. (2011) · Leukemia · doi:10.1038/leu.2011.321 · Cited by 87
Plasencia, C., Martinez‐Balibrea, E., Martínez‐Cardús, A., Quinn, D. I., Abad, A., & Neamati, N. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.225 · Cited by 81
Mian, S. A., Smith, A. E., Kulasekararaj, A. G., Kizilors, A., Mohamedali, A. M., Lea, N. C., Mitsopoulos, K., Ford, K., Nasser, E., Seidl, T., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.075325 · Cited by 77
Significance of Polypyrimidine Tract–Binding Protein 1 Expression in Colorectal Cancer
Takahashi, H., Nishimura, J., Kagawa, Y., Kano, Y., Takahashi, Y., Wu, X., Hiraki, M., Hamabe, A., Konno, M., Haraguchi, N., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0142 · Cited by 76
Grellscheid, S., Dalgliesh, C., Storbeck, M., Best, A., Liu, Y., Jakubik, M., Mende, Y., Ehrmann, I., Curk, T., Rossbach, K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002390 · Cited by 75
Angeloni, D. (2007) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elm007 · Cited by 71
Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy
Lal, D., Trucks, H., Møller, R. S., Hjalgrim, H., Koeleman, B. P. C., de Kovel, C. G. F., Visscher, F., Weber, Y. G., Lerche, H., Becker, F., et al. (2013) · Epilepsia · doi:10.1111/epi.12084 · Cited by 67
Expression of RBM5‐related factors in primary breast tissue
Rintala‐Maki, N. D., Goard, C. A., Langdon, C. E., Wall, V. E., Traulsen, K. E. A., Morin, C. D., Bonin, M., & Sutherland, L. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21134 · Cited by 67
Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
Wang, Z., Jeon, H. Y., Rigo, F., Bennett, C. F., & Krainer, A. R. (2012) · Open Biology · doi:10.1098/rsob.120133 · Cited by 67
Self-citationTransformer 2β and miR-204 regulate apoptosis through competitive binding to 3′ UTR of BCL2 mRNA
Kuwano, Y., Nishida, K., Kajita, K., Satake, Y., Akaike, Y., Fujita, K., Kano, S., Masuda, K., & Rokutan, K. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.176 · Cited by 67
Zhou, R., Shanas, R., Nelson, M. A., Bhattacharyya, A., & Shi, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24744 · Cited by 65
The tumor suppressing effects of QKI-5 in prostate cancer: A novel diagnostic and prognostic protein
Zhao, Y. D., Zhang, G., Wei, M., Lu, X., Fu, H.-Y., Feng, F., Wang, S., Wei, L., Wu, N., Lu, Z., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26722 · Cited by 63
Rare SF3B1 R625 mutations in cutaneous melanoma
Kong, Y., Krauthammer, M. O., & Halaban, R. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000071 · Cited by 63
Mende, Y., Jakubik, M., Rießland, M., Schoenen, F. J., Roßbach, K., Kleinridders, A., Köhler, C. N., Buch, T., & Wirth, B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq094 · Cited by 63
Blaustein, M., Pelisch, F., Coso, O. A., Bissell, M. J., Kornblihtt, A. R., & Srebrow, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314260200 · Cited by 60
Verduci, L., Simili, M., Rizzo, M., Mercatanti, A., Evangelista, M., Mariani, L., Rainaldi, G., & Pitto, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114736 · Cited by 59
Wang, C., Norton, J. T., Ghosh, S., Kim, J., Fushimi, K., Wu, J. Y., Stack, M. S., & Huang, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803682200 · Cited by 54
Modulation of Alternative Splicing with Chemical Compounds in New Therapeutics for Human Diseases
Ohe, K., & Hagiwara, M. (2015) · ACS Chemical Biology · doi:10.1021/cb500697f · Cited by 52
Splicing factor TRA2B is required for neural progenitor survival
Roberts, J. M., Ennajdaoui, H., Edmondson, C., Wirth, B., Sanford, J. R., & Chen, B. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23405 · Cited by 47
Huang, C., Shen, C., Wang, H.-W., Wu, P., & Cheng, C. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.06.001 · Cited by 46
SRPK1: A cisplatin sensitive protein expressed in retinoblastoma
Krishnakumar, S., Mohan, A., Kandalam, M., Ramkumar, H. L., Venkatesan, N., & Das, R. R. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21088 · Cited by 46
Zhao, L., Li, R., Shao, C., Li, P., Liu, J., & Wang, K. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-247 · Cited by 45
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer
Leontieva, O. V., & Ionov, Y. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7679 · Cited by 45
Roychoudhury, P., & Chaudhuri, K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603911 · Cited by 39
QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2
Lu, W., Feng, F., Xu, J., Lu, X., Wang, S., Wang, L., Lu, H., Wei, M., Yang, G., Wang, L., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29502 · Cited by 32
Hirschfeld, M., Ouyang, Y. Q., Jaeger, M., Erbes, T., Orlowska‐Volk, M., Hausen, A. Z., & Stickeler, E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1088-1 · Cited by 32
Novel splicing-factor mutations in juvenile myelomonocytic leukemia
Takita, J., Yoshida, K., Sanada, M., Nishimura, R., Okubo, J., Motomura, A., Hiwatari, M., Oki, K., Igarashi, T., Hayashi, Y., et al. (2012) · Leukemia · doi:10.1038/leu.2012.45 · Cited by 12
Weems, J. M., & Klemke, R. L. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-4464 · Cited by 8
Cited by
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Self-citationThe physiology of alternative splicing
Marasco, L. E., & Kornblihtt, A. R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00545-z · Cited by 505
Nuclear speckles: molecular organization, biological function and role in disease
Galganski, L., Urbanek, M. O., & Krzyzosiak, W. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx759 · Cited by 499
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 497
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Wu, Q., Schapira, M., Arrowsmith, C. H., & Barsyte-Lovejoy, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00159-8 · Cited by 419
Metadata
- Authors
- Anczuków, O., & Krainer, A. R.
- Venue
- RNA
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-08-16
- Volume
- 22
- Issue
- 9
- Pages
- 1285-1301
- ISSN
- 1355-8382 (ISSN-L)
- 1469-9001
- OpenAlex
- W2515668871
- Cited by
- 302
- References
- 165
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.